[S-8] Spero Therapeutics, Inc. Employee Benefit Plan Registration
Spero Therapeutics registered an additional 3,000,000 shares of common stock under its 2017 Stock Incentive Plan, as amended, representing an increase in shares reserved for employee awards. The registration statement incorporates by reference prior Form S-8 filings for the same plan and includes key exhibits such as the amended plan, forms of award agreements, counsel opinion and the independent auditor's consent.
Spero Therapeutics ha registrato ulteriori 3.000.000 azioni ordinarie ai sensi del suo Piano di Incentivazione Azionaria 2017, così modificato, aumentando le azioni riservate per i riconoscimenti ai dipendenti. La dichiarazione di registrazione incorpora per riferimento le precedenti presentazioni sul modulo S-8 relative allo stesso piano e include allegati principali quali il piano modificato, i moduli dei contratti di assegnazione, il parere legale e il consenso del revisore indipendente.
Spero Therapeutics registró 3.000.000 acciones ordinarias adicionales bajo su Plan de Incentivos en Acciones 2017, según enmendado, aumentando las acciones reservadas para premios a empleados. La declaración de registro incorpora por referencia las presentaciones previas en el Formulario S-8 del mismo plan e incluye anexos clave como el plan enmendado, los modelos de acuerdos de adjudicación, el dictamen legal y el consentimiento del auditor independiente.
Spero Therapeutics는 자사의 2017년 주식 인센티브 플랜(수정본)에 따라 보통주 3,000,000주를 추가로 등록하여 직원 보상용으로 예약된 주식 수를 늘렸습니다. 등록명세서는 동일한 플랜에 대한 이전 Form S-8 제출을 참조로 포함하며, 수정된 플랜, 수상 계약서 양식, 법무 의견서 및 독립 감사인의 동의서 등 주요 첨부문서를 포함합니다.
Spero Therapeutics a enregistré 3 000 000 actions ordinaires supplémentaires dans le cadre de son plan d'intéressement en actions 2017, tel que modifié, augmentant ainsi le nombre d'actions réservées aux attributions aux employés. La déclaration d'enregistrement incorpore par référence les dépôts antérieurs au formulaire S-8 relatifs au même plan et comprend des pièces essentielles telles que le plan modifié, les modèles de conventions d'attribution, l'avis du conseil juridique et le consentement de l'auditeur indépendant.
Spero Therapeutics hat zusätzlich 3.000.000 Stammaktien im Rahmen seines 2017 Aktienanreizplans, in der geänderten Fassung registriert, wodurch die für Mitarbeiterzuwendungen reservierten Aktien erhöht wurden. Die Registrierungserklärung nimmt frühere Form S-8-Einreichungen für denselben Plan durch Verweis auf und enthält wesentliche Anlagen wie den geänderten Plan, Muster der Zuwendungsvereinbarungen, die Rechtsmeinung und die Zustimmung des unabhängigen Abschlussprüfers.
- Registered 3,000,000 additional shares under the 2017 Stock Incentive Plan, increasing the pool for employee awards.
- Filing includes counsel opinion and PwC consent, indicating completion of standard legal and accounting reviews and required exhibits.
- None.
Insights
Routine equity registration to support employee compensation; limited immediate investor impact.
The filing registers 3,000,000 additional common shares for issuance under the company’s 2017 Stock Incentive Plan, which permits future grants to employees and service providers. The use of incorporation by reference to prior Form S-8s and inclusion of legal and audit exhibits (counsel opinion and PwC consent) indicate a standard, procedural filing to ensure shares are available for compensation programs. Impact on capital structure depends on future awards; the filing itself is administrative.
Board-authorized amendment expands the equity pool and follows standard governance procedures.
The registration statement documents an increase in the reserve under the 2017 Stock Incentive Plan and lists supporting exhibits including the amended plan and forms of option and RSU agreements. The filing also shows executed powers of attorney and board/member signatures, reflecting typical corporate approvals for employee equity programs. As a procedural governance action, the filing is not materially transformative on its own.
Spero Therapeutics ha registrato ulteriori 3.000.000 azioni ordinarie ai sensi del suo Piano di Incentivazione Azionaria 2017, così modificato, aumentando le azioni riservate per i riconoscimenti ai dipendenti. La dichiarazione di registrazione incorpora per riferimento le precedenti presentazioni sul modulo S-8 relative allo stesso piano e include allegati principali quali il piano modificato, i moduli dei contratti di assegnazione, il parere legale e il consenso del revisore indipendente.
Spero Therapeutics registró 3.000.000 acciones ordinarias adicionales bajo su Plan de Incentivos en Acciones 2017, según enmendado, aumentando las acciones reservadas para premios a empleados. La declaración de registro incorpora por referencia las presentaciones previas en el Formulario S-8 del mismo plan e incluye anexos clave como el plan enmendado, los modelos de acuerdos de adjudicación, el dictamen legal y el consentimiento del auditor independiente.
Spero Therapeutics는 자사의 2017년 주식 인센티브 플랜(수정본)에 따라 보통주 3,000,000주를 추가로 등록하여 직원 보상용으로 예약된 주식 수를 늘렸습니다. 등록명세서는 동일한 플랜에 대한 이전 Form S-8 제출을 참조로 포함하며, 수정된 플랜, 수상 계약서 양식, 법무 의견서 및 독립 감사인의 동의서 등 주요 첨부문서를 포함합니다.
Spero Therapeutics a enregistré 3 000 000 actions ordinaires supplémentaires dans le cadre de son plan d'intéressement en actions 2017, tel que modifié, augmentant ainsi le nombre d'actions réservées aux attributions aux employés. La déclaration d'enregistrement incorpore par référence les dépôts antérieurs au formulaire S-8 relatifs au même plan et comprend des pièces essentielles telles que le plan modifié, les modèles de conventions d'attribution, l'avis du conseil juridique et le consentement de l'auditeur indépendant.
Spero Therapeutics hat zusätzlich 3.000.000 Stammaktien im Rahmen seines 2017 Aktienanreizplans, in der geänderten Fassung registriert, wodurch die für Mitarbeiterzuwendungen reservierten Aktien erhöht wurden. Die Registrierungserklärung nimmt frühere Form S-8-Einreichungen für denselben Plan durch Verweis auf und enthält wesentliche Anlagen wie den geänderten Plan, Muster der Zuwendungsvereinbarungen, die Rechtsmeinung und die Zustimmung des unabhängigen Abschlussprüfers.
FAQ
What did Spero Therapeutics (SPRO) register on Form S-8?
Does this registration change the total number of shares available under the plan?
What exhibits are included with the S-8 filing for SPRO?
What is Spero Therapeutics' filer status as shown in the filing?
Who executed the registration statement for SPRO?
